Clinical trial registry record

Sarcopenia, Active Aging and Oral Microbiota. Effects of HIIT in Older Adults

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated April 27, 2022.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05220670
Last registry update
April 27, 2022
Status
Completed
Phase
Phase not reported
Sponsor
University of Jaén
Enrollment
90
Countries
Spain
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · TREATMENT · TRIPLE
Evidence population
Human clinical study registration
Participants
90
Population
ALL · 65 Years
Duration
2021-12-20 to 2022-04-11
Intervention
HIIT; MICT
Comparator
Control Group
Outcomes measured
Handgrip Strength — Up to twelve weeks; Relative abundance — Up to twelve weeks; Biodiversity — Up to twelve weeks; ABC-16 (Activities Specific Balance Confidence Scale) — Up to twelve weeks; FES-I (Falls Efficacy Scale-International) — Up to twelve weeks; PSQI (Pittsburgh Sleep Quality Index) — Up to twelve weeks; HADS (The Hospital Anxiety And Depression) — Up to twelve weeks; Percent of Body Fat (%) — Up to twelve weeks; BMI (Body Mass Index) — Up to twelve weeks; TUG (Timed Up and Go test) — Up to twelve weeks; Short Physical Performance Battery (SPPB) — Up to twelve weeks; Stabilometric Platform — Up to twelve weeks; FSS (Fatigue Severity Scale) — Up to twelve weeks; SF-36 (The Short Form-36 Health Survey) — Up to twelve weeks
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: aging, older adult. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

sarcopenia
Open primary sourceExport JSON